Taurodeoxycholate
Trade name: Nusepin
Small moleculeexperimental
Clinical trial activity
6 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
3
Phase 3
1
Phase 4
0
Earliest trial started Jan 29, 2018 (NCT03492398)
Timeline
Indications
Mechanism of action
NLRP3 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06024499 | Phase 2 | Dec 31, 2023 | Shaperon |
| NCT05352347 | Phase 2/Phase 3 (Phase 3) | Apr 12, 2022 | Shaperon |
| NCT04565379 | Phase 2 | Sep 25, 2020 | Shaperon |
| NCT04530643 | Phase 2 | Jun 19, 2020 | Shaperon |
| NCT04255979 | Phase 1 | Dec 5, 2019 | Seoul National University, Shaperon |
| NCT03492398 | Phase 1 | Jan 29, 2018 | Seoul National University, Shaperon |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Shaperon | For profit | 6 | 6 | 3 | 2018 |
| Seoul National University | Academic/Hospital | 2 | 0 | 1 | 2018 |
2 organizations
Page 1 / 1